Department of Medical Molecular Biology, Beijing Institute of Biotechnology, Beijing 100850, P.R. China.
Department of Oncology, Chinese PLA General Hospital, Beijing 100853, P.R. China.
Int J Biol Sci. 2021 Jun 22;17(10):2622-2632. doi: 10.7150/ijbs.59939. eCollection 2021.
Lung adenocarcinoma (LUAD) is a common type of lung cancer with high frequent metastasis and a high death rate. However, genes responsible for LUAD metastasis are still largely unknown. Here, we identify an important role of ras homolog family member V (RHOV) in LUAD metastasis using a combination of bioinformatic analysis and functional experiments. Bioinformatic analysis shows five hub LUAD metastasis driver genes (RHOV, ZIC5, CYP4B1, GPR18 and TCP10L2), among which RHOV is the most significant gene associated with LUAD metastasis. High RHOV expression predicted shorter overall survival in LUAD patients. RHOV overexpression promotes proliferation, migration, and invasion of LUAD cells whereas RHOV knockdown inhibits these biological behaviors. Moreover, knockdown of RHOV suppresses LUAD tumor growth and metastasis in nude mice. Mechanistically, RHOV activates Jun N-terminal Kinase (JNK)/c-Jun signalling pathway, an important pathway in lung cancer development and progression, and regulates the expression of markers of epithelial-to-mesenchymal transition, a process involved in cancer cell migration, invasion and metastasis. RHOV-induced malignant biological behaviors are inhibited by pyrazolanthrone, a JNK inhibitor. Our findings indicate a critical role of RHOV in LUAD metastasis and may provide a biomarker for prognostic prediction and a target for LUAD therapy.
肺腺癌 (LUAD) 是一种常见的肺癌类型,具有高频转移和高死亡率的特点。然而,导致 LUAD 转移的基因仍在很大程度上未知。在这里,我们使用生物信息学分析和功能实验相结合的方法,鉴定出 ras 同源家族成员 V (RHOV) 在 LUAD 转移中的重要作用。生物信息学分析显示了五个 LUAD 转移驱动基因(RHOV、ZIC5、CYP4B1、GPR18 和 TCP10L2)的重要作用,其中 RHOV 是与 LUAD 转移最显著相关的基因。高 RHOV 表达预示着 LUAD 患者的总生存期更短。RHOV 过表达促进 LUAD 细胞的增殖、迁移和侵袭,而 RHOV 敲低则抑制这些生物学行为。此外,RHOV 敲低抑制了裸鼠中 LUAD 肿瘤的生长和转移。在机制上,RHOV 激活了 Jun N-末端激酶 (JNK)/c-Jun 信号通路,这是肺癌发生和发展的一个重要通路,并调节上皮间质转化标志物的表达,这是一个涉及癌细胞迁移、侵袭和转移的过程。JNK 抑制剂吡唑烷酮可抑制 RHOV 诱导的恶性生物学行为。我们的研究结果表明 RHOV 在 LUAD 转移中的关键作用,并可能为预后预测提供生物标志物,并为 LUAD 治疗提供新的靶点。
Cell Oncol (Dordr). 2021-10
Int Immunopharmacol. 2024-10-25
J Exp Clin Cancer Res. 2019-2-21
Cancer Biol Ther. 2025-12
Cancers (Basel). 2020-12-2
Signal Transduct Target Ther. 2020-12-2
Trends Cancer. 2020-11
Int J Mol Sci. 2020-4-9
Trends Mol Med. 2019-5-30